- Published on
KembaraXtra-Medicine – Methanol Poisoning
Methanol is a colorless, volatile liquid that is rapidly absorbed within 30–60 minutes and metabolized by the liver, with a half-life of approximately 4–8 hours. Methanol itself is relatively nontoxic and produces inebriation similar to ethanol. Toxicity results from its metabolites, formaldehyde and formic acid, which inhibit cytochrome oxidase and disrupt cellular respiration. Formic acid is primarily responsible for severe metabolic acidosis, visual toxicity, and mortality, as it is directly toxic to the retina and optic nerve. Methanol is metabolized in three steps: conversion to formaldehyde by alcohol dehydrogenase, rapid conversion of formaldehyde to formic acid by aldehyde dehydrogenase, and folate-dependent degradation of formic acid to carbon dioxide and water. The first and third steps are rate-limiting.
Common sources of methanol exposure include windshield washer fluid, wood alcohol, carburetor cleaners, fuel antifreeze solutions, formalin, gasoline, paint solvents, household cleaners, Sterno cans, moonshine, model airplane fuel, photocopying fluids, and perfumes. Ingestion may be intentional or accidental, and inhalational exposure can occur with solvent abuse.
Clinical manifestations often begin with gastrointestinal symptoms such as anorexia, nausea, vomiting, and abdominal pain. Central nervous system findings include headache, dizziness, confusion, inebriation, seizures, and coma. Ophthalmologic symptoms are characteristic and include blurry or hazy vision, photophobia, “snowfield” vision, central scotomas, and potentially permanent blindness. Patients may present without a clear ingestion history but instead with an unexplained high anion gap metabolic acidosis and elevated osmol gap. On examination, findings may include tachypnea, altered mental status, optic disc hyperemia or pallor, papilledema, and afferent pupillary defects.
Evaluation requires a careful history of all possible ingestions and attention to visual complaints, along with a funduscopic examination. Essential laboratory tests include arterial blood gas analysis, serum electrolytes, glucose, BUN, creatinine, measured serum osmolality, and serum levels of methanol, ethanol, ethylene glycol, and isopropyl alcohol. The anion gap and osmol gap should be calculated. The osmol gap is most useful early in poisoning, as methanol is osmotically active, whereas its toxic metabolites are not. Importantly, a normal osmol gap does not exclude methanol poisoning, especially in late presenters. Serum methanol levels confirm the diagnosis, though levels may be undetectable late in the course when severe acidosis is present.
Management begins with prompt stabilization of airway, breathing, and circulation, along with administration of dextrose, naloxone, and thiamine for altered mental status. Further absorption is limited by supportive care, as gastric lavage and activated charcoal have limited benefit due to rapid methanol absorption. The cornerstone of treatment is inhibition of alcohol dehydrogenase to prevent formation of toxic metabolites. Fomepizole is the preferred antidote and should be initiated promptly when methanol ingestion is suspected, even before serum levels return. Ethanol infusion is an alternative when fomepizole is unavailable but is associated with significant adverse effects and requires close monitoring.
Hemodialysis plays a critical role by enhancing elimination of methanol and its metabolites and correcting severe acidosis. Indications include visual symptoms, severe or refractory metabolic acidosis, renal failure, ingestion of large amounts of methanol, or serum methanol levels greater than 25 mg/dL. Hemodialysis is continued until methanol levels fall below 25 mg/dL and acidosis resolves. Adjunctive therapy with folic or folinic acid is recommended to enhance metabolism of formic acid. Sodium bicarbonate is used to correct severe acidosis, with the goal of maintaining a normal serum pH.
Patients with significant exposure require hospital admission, often to the intensive care unit, and transfer to a facility with antidote availability and hemodialysis capability if needed. Asymptomatic patients with low methanol levels, normal acid–base status, and stable electrolytes may be considered for discharge. Psychiatric evaluation is important in cases of intentional ingestion. Early recognition and treatment are essential, as delays greatly increase the risk of blindness and death.
Methanol is a colorless, volatile liquid that is rapidly absorbed within 30–60 minutes and metabolized by the liver, with a half-life of approximately 4–8 hours. Methanol itself is relatively nontoxic and produces inebriation similar to ethanol. Toxicity results from its metabolites, formaldehyde and formic acid, which inhibit cytochrome oxidase and disrupt cellular respiration. Formic acid is primarily responsible for severe metabolic acidosis, visual toxicity, and mortality, as it is directly toxic to the retina and optic nerve. Methanol is metabolized in three steps: conversion to formaldehyde by alcohol dehydrogenase, rapid conversion of formaldehyde to formic acid by aldehyde dehydrogenase, and folate-dependent degradation of formic acid to carbon dioxide and water. The first and third steps are rate-limiting.
Common sources of methanol exposure include windshield washer fluid, wood alcohol, carburetor cleaners, fuel antifreeze solutions, formalin, gasoline, paint solvents, household cleaners, Sterno cans, moonshine, model airplane fuel, photocopying fluids, and perfumes. Ingestion may be intentional or accidental, and inhalational exposure can occur with solvent abuse.
Clinical manifestations often begin with gastrointestinal symptoms such as anorexia, nausea, vomiting, and abdominal pain. Central nervous system findings include headache, dizziness, confusion, inebriation, seizures, and coma. Ophthalmologic symptoms are characteristic and include blurry or hazy vision, photophobia, “snowfield” vision, central scotomas, and potentially permanent blindness. Patients may present without a clear ingestion history but instead with an unexplained high anion gap metabolic acidosis and elevated osmol gap. On examination, findings may include tachypnea, altered mental status, optic disc hyperemia or pallor, papilledema, and afferent pupillary defects.
Evaluation requires a careful history of all possible ingestions and attention to visual complaints, along with a funduscopic examination. Essential laboratory tests include arterial blood gas analysis, serum electrolytes, glucose, BUN, creatinine, measured serum osmolality, and serum levels of methanol, ethanol, ethylene glycol, and isopropyl alcohol. The anion gap and osmol gap should be calculated. The osmol gap is most useful early in poisoning, as methanol is osmotically active, whereas its toxic metabolites are not. Importantly, a normal osmol gap does not exclude methanol poisoning, especially in late presenters. Serum methanol levels confirm the diagnosis, though levels may be undetectable late in the course when severe acidosis is present.
Management begins with prompt stabilization of airway, breathing, and circulation, along with administration of dextrose, naloxone, and thiamine for altered mental status. Further absorption is limited by supportive care, as gastric lavage and activated charcoal have limited benefit due to rapid methanol absorption. The cornerstone of treatment is inhibition of alcohol dehydrogenase to prevent formation of toxic metabolites. Fomepizole is the preferred antidote and should be initiated promptly when methanol ingestion is suspected, even before serum levels return. Ethanol infusion is an alternative when fomepizole is unavailable but is associated with significant adverse effects and requires close monitoring.
Hemodialysis plays a critical role by enhancing elimination of methanol and its metabolites and correcting severe acidosis. Indications include visual symptoms, severe or refractory metabolic acidosis, renal failure, ingestion of large amounts of methanol, or serum methanol levels greater than 25 mg/dL. Hemodialysis is continued until methanol levels fall below 25 mg/dL and acidosis resolves. Adjunctive therapy with folic or folinic acid is recommended to enhance metabolism of formic acid. Sodium bicarbonate is used to correct severe acidosis, with the goal of maintaining a normal serum pH.
Patients with significant exposure require hospital admission, often to the intensive care unit, and transfer to a facility with antidote availability and hemodialysis capability if needed. Asymptomatic patients with low methanol levels, normal acid–base status, and stable electrolytes may be considered for discharge. Psychiatric evaluation is important in cases of intentional ingestion. Early recognition and treatment are essential, as delays greatly increase the risk of blindness and death.
- Published on
KembaraXtra-Medicine – Methanol Poisoning
Methanol is a colorless, volatile liquid that is rapidly absorbed within 30–60 minutes and metabolized by the liver, with a half-life of approximately 4–8 hours. Methanol itself is relatively nontoxic and produces inebriation similar to ethanol. Toxicity results from its metabolites, formaldehyde and formic acid, which inhibit cytochrome oxidase and disrupt cellular respiration. Formic acid is primarily responsible for severe metabolic acidosis, visual toxicity, and mortality, as it is directly toxic to the retina and optic nerve. Methanol is metabolized in three steps: conversion to formaldehyde by alcohol dehydrogenase, rapid conversion of formaldehyde to formic acid by aldehyde dehydrogenase, and folate-dependent degradation of formic acid to carbon dioxide and water. The first and third steps are rate-limiting.
Common sources of methanol exposure include windshield washer fluid, wood alcohol, carburetor cleaners, fuel antifreeze solutions, formalin, gasoline, paint solvents, household cleaners, Sterno cans, moonshine, model airplane fuel, photocopying fluids, and perfumes. Ingestion may be intentional or accidental, and inhalational exposure can occur with solvent abuse.
Clinical manifestations often begin with gastrointestinal symptoms such as anorexia, nausea, vomiting, and abdominal pain. Central nervous system findings include headache, dizziness, confusion, inebriation, seizures, and coma. Ophthalmologic symptoms are characteristic and include blurry or hazy vision, photophobia, “snowfield” vision, central scotomas, and potentially permanent blindness. Patients may present without a clear ingestion history but instead with an unexplained high anion gap metabolic acidosis and elevated osmol gap. On examination, findings may include tachypnea, altered mental status, optic disc hyperemia or pallor, papilledema, and afferent pupillary defects.
Evaluation requires a careful history of all possible ingestions and attention to visual complaints, along with a funduscopic examination. Essential laboratory tests include arterial blood gas analysis, serum electrolytes, glucose, BUN, creatinine, measured serum osmolality, and serum levels of methanol, ethanol, ethylene glycol, and isopropyl alcohol. The anion gap and osmol gap should be calculated. The osmol gap is most useful early in poisoning, as methanol is osmotically active, whereas its toxic metabolites are not. Importantly, a normal osmol gap does not exclude methanol poisoning, especially in late presenters. Serum methanol levels confirm the diagnosis, though levels may be undetectable late in the course when severe acidosis is present.
Management begins with prompt stabilization of airway, breathing, and circulation, along with administration of dextrose, naloxone, and thiamine for altered mental status. Further absorption is limited by supportive care, as gastric lavage and activated charcoal have limited benefit due to rapid methanol absorption. The cornerstone of treatment is inhibition of alcohol dehydrogenase to prevent formation of toxic metabolites. Fomepizole is the preferred antidote and should be initiated promptly when methanol ingestion is suspected, even before serum levels return. Ethanol infusion is an alternative when fomepizole is unavailable but is associated with significant adverse effects and requires close monitoring.
Hemodialysis plays a critical role by enhancing elimination of methanol and its metabolites and correcting severe acidosis. Indications include visual symptoms, severe or refractory metabolic acidosis, renal failure, ingestion of large amounts of methanol, or serum methanol levels greater than 25 mg/dL. Hemodialysis is continued until methanol levels fall below 25 mg/dL and acidosis resolves. Adjunctive therapy with folic or folinic acid is recommended to enhance metabolism of formic acid. Sodium bicarbonate is used to correct severe acidosis, with the goal of maintaining a normal serum pH.
Patients with significant exposure require hospital admission, often to the intensive care unit, and transfer to a facility with antidote availability and hemodialysis capability if needed. Asymptomatic patients with low methanol levels, normal acid–base status, and stable electrolytes may be considered for discharge. Psychiatric evaluation is important in cases of intentional ingestion. Early recognition and treatment are essential, as delays greatly increase the risk of blindness and death.
Methanol is a colorless, volatile liquid that is rapidly absorbed within 30–60 minutes and metabolized by the liver, with a half-life of approximately 4–8 hours. Methanol itself is relatively nontoxic and produces inebriation similar to ethanol. Toxicity results from its metabolites, formaldehyde and formic acid, which inhibit cytochrome oxidase and disrupt cellular respiration. Formic acid is primarily responsible for severe metabolic acidosis, visual toxicity, and mortality, as it is directly toxic to the retina and optic nerve. Methanol is metabolized in three steps: conversion to formaldehyde by alcohol dehydrogenase, rapid conversion of formaldehyde to formic acid by aldehyde dehydrogenase, and folate-dependent degradation of formic acid to carbon dioxide and water. The first and third steps are rate-limiting.
Common sources of methanol exposure include windshield washer fluid, wood alcohol, carburetor cleaners, fuel antifreeze solutions, formalin, gasoline, paint solvents, household cleaners, Sterno cans, moonshine, model airplane fuel, photocopying fluids, and perfumes. Ingestion may be intentional or accidental, and inhalational exposure can occur with solvent abuse.
Clinical manifestations often begin with gastrointestinal symptoms such as anorexia, nausea, vomiting, and abdominal pain. Central nervous system findings include headache, dizziness, confusion, inebriation, seizures, and coma. Ophthalmologic symptoms are characteristic and include blurry or hazy vision, photophobia, “snowfield” vision, central scotomas, and potentially permanent blindness. Patients may present without a clear ingestion history but instead with an unexplained high anion gap metabolic acidosis and elevated osmol gap. On examination, findings may include tachypnea, altered mental status, optic disc hyperemia or pallor, papilledema, and afferent pupillary defects.
Evaluation requires a careful history of all possible ingestions and attention to visual complaints, along with a funduscopic examination. Essential laboratory tests include arterial blood gas analysis, serum electrolytes, glucose, BUN, creatinine, measured serum osmolality, and serum levels of methanol, ethanol, ethylene glycol, and isopropyl alcohol. The anion gap and osmol gap should be calculated. The osmol gap is most useful early in poisoning, as methanol is osmotically active, whereas its toxic metabolites are not. Importantly, a normal osmol gap does not exclude methanol poisoning, especially in late presenters. Serum methanol levels confirm the diagnosis, though levels may be undetectable late in the course when severe acidosis is present.
Management begins with prompt stabilization of airway, breathing, and circulation, along with administration of dextrose, naloxone, and thiamine for altered mental status. Further absorption is limited by supportive care, as gastric lavage and activated charcoal have limited benefit due to rapid methanol absorption. The cornerstone of treatment is inhibition of alcohol dehydrogenase to prevent formation of toxic metabolites. Fomepizole is the preferred antidote and should be initiated promptly when methanol ingestion is suspected, even before serum levels return. Ethanol infusion is an alternative when fomepizole is unavailable but is associated with significant adverse effects and requires close monitoring.
Hemodialysis plays a critical role by enhancing elimination of methanol and its metabolites and correcting severe acidosis. Indications include visual symptoms, severe or refractory metabolic acidosis, renal failure, ingestion of large amounts of methanol, or serum methanol levels greater than 25 mg/dL. Hemodialysis is continued until methanol levels fall below 25 mg/dL and acidosis resolves. Adjunctive therapy with folic or folinic acid is recommended to enhance metabolism of formic acid. Sodium bicarbonate is used to correct severe acidosis, with the goal of maintaining a normal serum pH.
Patients with significant exposure require hospital admission, often to the intensive care unit, and transfer to a facility with antidote availability and hemodialysis capability if needed. Asymptomatic patients with low methanol levels, normal acid–base status, and stable electrolytes may be considered for discharge. Psychiatric evaluation is important in cases of intentional ingestion. Early recognition and treatment are essential, as delays greatly increase the risk of blindness and death.
- Published on
KembaraXtra-Medicine – Mesenteric Ischemia
Mesenteric ischemia is a serious condition caused by decreased or completely occluded blood flow through the mesenteric vessels, leading to ischemia or infarction of the bowel. It may result from arterial obstruction, venous thrombosis, or low-flow states. Although it accounts for only about 1 in 1,000 hospital admissions and 1–2% of admissions for abdominal pain, it carries a very high mortality rate of 60–70%, especially when diagnosis or treatment is delayed beyond 24 hours. Most cases occur in patients older than 50 years.
Acute mesenteric arterial embolism is the most common cause, accounting for approximately half of acute cases. It typically affects elderly patients and most often arises from cardiac sources such as atrial fibrillation, valvular disease, or ventricular thrombus after myocardial infarction. Emboli usually lodge several centimeters distal to the origin of the superior mesenteric artery, sparing proximal bowel segments. Mesenteric arterial thrombosis accounts for about 15% of cases and usually develops from rupture of an atherosclerotic plaque in patients with chronic mesenteric ischemia, often preceded by longstanding postprandial abdominal pain known as intestinal angina.
Mesenteric venous thrombosis represents 5–15% of cases and tends to have a more subacute presentation. It occurs more often in younger patients with underlying hypercoagulable states, including inherited thrombophilias, malignancy, pregnancy, estrogen therapy, sickle cell disease, sepsis, renal failure on dialysis, or recent trauma. Nonocclusive mesenteric ischemia accounts for 20–30% of cases and is associated with low cardiac output states such as congestive heart failure, sepsis, hypotension, hypovolemia, or recent use of vasopressors. This form is associated with poorer survival. Chronic mesenteric ischemia presents with postprandial abdominal pain, food avoidance, and weight loss. Rare causes include mesenteric arterial dissection, median arcuate ligament syndrome, external compression by tumors, and certain medications such as digitalis, ergotamine, cocaine, and vasopressin.
Clinically, acute mesenteric ischemia classically presents with sudden-onset, severe, diffuse abdominal pain that is out of proportion to physical examination findings. Associated symptoms include nausea, vomiting, diarrhea, and occult gastrointestinal bleeding. Elderly patients may present atypically with altered mental status, tachypnea, or tachycardia. As ischemia progresses to infarction, late findings such as peritoneal signs, abdominal distention, and hypoactive bowel sounds may appear.
Laboratory findings are often nonspecific. Leukocytosis is common, metabolic acidosis may be present, and serum lactate is elevated in most patients with advanced disease, correlating with poor prognosis. Imaging plays a crucial role in diagnosis. Plain abdominal radiographs are often normal early but may show pneumatosis intestinalis or pneumobilia in advanced cases. Multidetector CT angiography has become the imaging modality of choice, allowing visualization of mesenteric vessels and bowel wall changes. Angiography, once the gold standard, is now used selectively for both diagnosis and therapeutic intervention.
Management requires rapid recognition and aggressive treatment. Initial stabilization focuses on airway, breathing, and circulation, with prompt fluid resuscitation. Patients should be kept NPO, a nasogastric tube placed for decompression, and electrolyte abnormalities corrected. Broad-spectrum intravenous antibiotics covering bowel flora are essential. Systemic anticoagulation with heparin is recommended unless contraindicated. Vasoconstrictive medications should be avoided when possible, as they may worsen mesenteric perfusion.
Definitive management depends on the underlying cause and severity. Intra-arterial vasodilators such as papaverine may be administered during angiography for vasospasm or nonocclusive ischemia. Thrombolysis or surgical revascularization may be required for arterial occlusion. Any patient with peritoneal signs requires urgent exploratory laparotomy. All patients with mesenteric ischemia require hospital admission and early surgical consultation, as delays in diagnosis and intervention dramatically increase mortality.
Mesenteric ischemia is a serious condition caused by decreased or completely occluded blood flow through the mesenteric vessels, leading to ischemia or infarction of the bowel. It may result from arterial obstruction, venous thrombosis, or low-flow states. Although it accounts for only about 1 in 1,000 hospital admissions and 1–2% of admissions for abdominal pain, it carries a very high mortality rate of 60–70%, especially when diagnosis or treatment is delayed beyond 24 hours. Most cases occur in patients older than 50 years.
Acute mesenteric arterial embolism is the most common cause, accounting for approximately half of acute cases. It typically affects elderly patients and most often arises from cardiac sources such as atrial fibrillation, valvular disease, or ventricular thrombus after myocardial infarction. Emboli usually lodge several centimeters distal to the origin of the superior mesenteric artery, sparing proximal bowel segments. Mesenteric arterial thrombosis accounts for about 15% of cases and usually develops from rupture of an atherosclerotic plaque in patients with chronic mesenteric ischemia, often preceded by longstanding postprandial abdominal pain known as intestinal angina.
Mesenteric venous thrombosis represents 5–15% of cases and tends to have a more subacute presentation. It occurs more often in younger patients with underlying hypercoagulable states, including inherited thrombophilias, malignancy, pregnancy, estrogen therapy, sickle cell disease, sepsis, renal failure on dialysis, or recent trauma. Nonocclusive mesenteric ischemia accounts for 20–30% of cases and is associated with low cardiac output states such as congestive heart failure, sepsis, hypotension, hypovolemia, or recent use of vasopressors. This form is associated with poorer survival. Chronic mesenteric ischemia presents with postprandial abdominal pain, food avoidance, and weight loss. Rare causes include mesenteric arterial dissection, median arcuate ligament syndrome, external compression by tumors, and certain medications such as digitalis, ergotamine, cocaine, and vasopressin.
Clinically, acute mesenteric ischemia classically presents with sudden-onset, severe, diffuse abdominal pain that is out of proportion to physical examination findings. Associated symptoms include nausea, vomiting, diarrhea, and occult gastrointestinal bleeding. Elderly patients may present atypically with altered mental status, tachypnea, or tachycardia. As ischemia progresses to infarction, late findings such as peritoneal signs, abdominal distention, and hypoactive bowel sounds may appear.
Laboratory findings are often nonspecific. Leukocytosis is common, metabolic acidosis may be present, and serum lactate is elevated in most patients with advanced disease, correlating with poor prognosis. Imaging plays a crucial role in diagnosis. Plain abdominal radiographs are often normal early but may show pneumatosis intestinalis or pneumobilia in advanced cases. Multidetector CT angiography has become the imaging modality of choice, allowing visualization of mesenteric vessels and bowel wall changes. Angiography, once the gold standard, is now used selectively for both diagnosis and therapeutic intervention.
Management requires rapid recognition and aggressive treatment. Initial stabilization focuses on airway, breathing, and circulation, with prompt fluid resuscitation. Patients should be kept NPO, a nasogastric tube placed for decompression, and electrolyte abnormalities corrected. Broad-spectrum intravenous antibiotics covering bowel flora are essential. Systemic anticoagulation with heparin is recommended unless contraindicated. Vasoconstrictive medications should be avoided when possible, as they may worsen mesenteric perfusion.
Definitive management depends on the underlying cause and severity. Intra-arterial vasodilators such as papaverine may be administered during angiography for vasospasm or nonocclusive ischemia. Thrombolysis or surgical revascularization may be required for arterial occlusion. Any patient with peritoneal signs requires urgent exploratory laparotomy. All patients with mesenteric ischemia require hospital admission and early surgical consultation, as delays in diagnosis and intervention dramatically increase mortality.
- Published on
KembaraXtra-Medicine – Mercury Poisoning
Mercury poisoning results from exposure to mercury in one of three primary forms: elemental, inorganic salts, or organic mercury. Mercury exerts its toxic effects by reacting with sulfhydryl groups, leading to enzyme inhibition and disruption of cellular membranes. It also binds to phosphoryl, carboxyl, amide, and amine groups of enzymes, further impairing normal cellular function.
Exposure most commonly occurs through inhalation or ingestion, and less frequently through dermal contact. Occupational and environmental exposures are well recognized and include industries such as chlorine and caustic soda manufacturing, dentistry, photography, taxidermy, mercury mining, and the production of thermometers, batteries, lamps, plastics, paints, pigments, fireworks, and explosives. Contaminated seafood is a major source of organic mercury exposure in the general population.
The clinical presentation varies depending on the form of mercury involved. Elemental mercury exposure most often occurs through inhalation, with symptoms developing within hours. Patients may experience cough and dyspnea that can progress to noncardiogenic pulmonary edema, along with metallic taste, excessive salivation, weakness, nausea, diarrhea, fever, headaches, and visual disturbances. Subcutaneous or intravenous exposure may lead to granulomas, abscesses, or pulmonary embolization. Elemental mercury is relatively nontoxic when ingested orally due to poor gastrointestinal absorption.
Inorganic mercurial salt ingestion causes severe caustic gastrointestinal injury. Symptoms include abdominal pain, nausea, vomiting, diarrhea, sore throat, and a metallic taste. Hemorrhagic gastroenteritis with hematemesis and hematochezia may occur, along with acute tubular necrosis and renal failure. Acrodynia, also known as pink disease, is an idiosyncratic reaction seen mainly in children and is characterized by painful extremities, pink discoloration, and desquamation.
Organic mercury exposure, commonly through contaminated seafood, primarily affects the central nervous system. While mild gastrointestinal symptoms may occur acutely, delayed neurologic toxicity predominates and may take weeks to months to appear. Manifestations include paresthesias, ataxia, paralysis, visual field constriction, dysarthria, hearing loss, progressive cognitive decline, and death. Fetal exposure in utero is associated with particularly severe neurologic outcomes.
Diagnosis relies heavily on a detailed exposure history, including occupational risks and recent seafood consumption. Physical examination focuses on identifying respiratory distress, signs of caustic gastrointestinal injury, and neuropsychiatric abnormalities. Laboratory evaluation may reveal renal dysfunction, but mercury levels in blood or urine can be misleading, especially after recent seafood ingestion. Imaging studies such as chest radiographs may show pulmonary edema or metallic deposits, abdominal radiographs can identify ingested mercury, and head CT may demonstrate cerebellar atrophy in chronic cases.
Management begins with immediate removal from the source of exposure and stabilization of airway, breathing, and circulation. Supportive care includes oxygen, intravenous fluids for hypotension, and treatment of altered mental status with dextrose, thiamine, and naloxone when indicated. Elemental mercury inhalation requires close observation for delayed pulmonary edema. Inorganic mercury ingestion warrants aggressive fluid resuscitation and early treatment of shock or renal failure.
Chelation therapy is indicated for symptomatic patients. Dimercaptosuccinic acid (DMSA) is commonly used for organic and some elemental mercury exposures, while dimercaprol (British anti-Lewisite) is preferred for severe inorganic mercury poisoning. Activated charcoal may be used for recent ingestions. Surgical incision and drainage may be required for subcutaneous mercury deposits.
Hospital admission is recommended for patients with respiratory compromise, renal impairment, caustic gastrointestinal injury, or those requiring chelation therapy. Asymptomatic patients exposed to elemental mercury may be discharged after an adequate observation period. Follow-up includes repeat mercury testing, avoidance of seafood before testing, and referral to medical toxicology. Early recognition, thorough exposure history, and appropriate chelation are critical to reducing morbidity and preventing long-term neurologic sequelae.
Mercury poisoning results from exposure to mercury in one of three primary forms: elemental, inorganic salts, or organic mercury. Mercury exerts its toxic effects by reacting with sulfhydryl groups, leading to enzyme inhibition and disruption of cellular membranes. It also binds to phosphoryl, carboxyl, amide, and amine groups of enzymes, further impairing normal cellular function.
Exposure most commonly occurs through inhalation or ingestion, and less frequently through dermal contact. Occupational and environmental exposures are well recognized and include industries such as chlorine and caustic soda manufacturing, dentistry, photography, taxidermy, mercury mining, and the production of thermometers, batteries, lamps, plastics, paints, pigments, fireworks, and explosives. Contaminated seafood is a major source of organic mercury exposure in the general population.
The clinical presentation varies depending on the form of mercury involved. Elemental mercury exposure most often occurs through inhalation, with symptoms developing within hours. Patients may experience cough and dyspnea that can progress to noncardiogenic pulmonary edema, along with metallic taste, excessive salivation, weakness, nausea, diarrhea, fever, headaches, and visual disturbances. Subcutaneous or intravenous exposure may lead to granulomas, abscesses, or pulmonary embolization. Elemental mercury is relatively nontoxic when ingested orally due to poor gastrointestinal absorption.
Inorganic mercurial salt ingestion causes severe caustic gastrointestinal injury. Symptoms include abdominal pain, nausea, vomiting, diarrhea, sore throat, and a metallic taste. Hemorrhagic gastroenteritis with hematemesis and hematochezia may occur, along with acute tubular necrosis and renal failure. Acrodynia, also known as pink disease, is an idiosyncratic reaction seen mainly in children and is characterized by painful extremities, pink discoloration, and desquamation.
Organic mercury exposure, commonly through contaminated seafood, primarily affects the central nervous system. While mild gastrointestinal symptoms may occur acutely, delayed neurologic toxicity predominates and may take weeks to months to appear. Manifestations include paresthesias, ataxia, paralysis, visual field constriction, dysarthria, hearing loss, progressive cognitive decline, and death. Fetal exposure in utero is associated with particularly severe neurologic outcomes.
Diagnosis relies heavily on a detailed exposure history, including occupational risks and recent seafood consumption. Physical examination focuses on identifying respiratory distress, signs of caustic gastrointestinal injury, and neuropsychiatric abnormalities. Laboratory evaluation may reveal renal dysfunction, but mercury levels in blood or urine can be misleading, especially after recent seafood ingestion. Imaging studies such as chest radiographs may show pulmonary edema or metallic deposits, abdominal radiographs can identify ingested mercury, and head CT may demonstrate cerebellar atrophy in chronic cases.
Management begins with immediate removal from the source of exposure and stabilization of airway, breathing, and circulation. Supportive care includes oxygen, intravenous fluids for hypotension, and treatment of altered mental status with dextrose, thiamine, and naloxone when indicated. Elemental mercury inhalation requires close observation for delayed pulmonary edema. Inorganic mercury ingestion warrants aggressive fluid resuscitation and early treatment of shock or renal failure.
Chelation therapy is indicated for symptomatic patients. Dimercaptosuccinic acid (DMSA) is commonly used for organic and some elemental mercury exposures, while dimercaprol (British anti-Lewisite) is preferred for severe inorganic mercury poisoning. Activated charcoal may be used for recent ingestions. Surgical incision and drainage may be required for subcutaneous mercury deposits.
Hospital admission is recommended for patients with respiratory compromise, renal impairment, caustic gastrointestinal injury, or those requiring chelation therapy. Asymptomatic patients exposed to elemental mercury may be discharged after an adequate observation period. Follow-up includes repeat mercury testing, avoidance of seafood before testing, and referral to medical toxicology. Early recognition, thorough exposure history, and appropriate chelation are critical to reducing morbidity and preventing long-term neurologic sequelae.
- Published on
KembaraXtra-Medicine – Meningococcemia
Meningococcemia is a serious bacterial illness caused by Neisseria meningitidis. It can present in several clinical forms, ranging from mild, self-limited disease to rapidly fatal overwhelming sepsis. Other manifestations include meningococcal meningitis, chronic or occult meningococcemia, septic arthritis, and less commonly localized infections. Transmission occurs through close contact with an infected person or an asymptomatic carrier, with intimate kissing and cigarette smoking recognized as independent risk factors.
The disease is caused by Neisseria meningitidis, a gram-negative diplococcus with multiple serotypes. Although many serotypes exist, most infections are caused by serogroups A, B, C, X, Y, and W135, with serogroup B being the most common in the United States. The organism colonizes the human nasopharynx, the only natural reservoir, and may invade the bloodstream after penetrating nasopharyngeal epithelial cells. Circulating bacteria are normally cleared by the spleen, but meningococci produce a potent endotoxin, lipooligosaccharide, which plays a central role in vascular injury, skin manifestations, adrenal hemorrhage, and circulatory collapse. Carrier rates increase with age, reaching up to 30–40% in young adults, while young children have lower immunity and higher infection risk. Disease incidence peaks in fall and spring and is higher in crowded living conditions such as military barracks and dormitories.
Clinical presentation varies widely. Mild meningococcemia is the most common form and is often preceded by an upper respiratory infection. Patients develop fever, chills, myalgias, arthralgias, and malaise, and the illness may resolve spontaneously over several days. However, this form can progress to meningitis or overwhelming sepsis. Overwhelming meningococcal sepsis occurs in approximately 10% of cases and carries a high mortality rate, with most deaths occurring within the first 48 hours. The onset is abrupt, and early symptoms may appear deceptively mild, including low-grade tachycardia, tachypnea, hypotension, fever, vomiting, headache, rash, and muscle tenderness. Infants may present with lethargy, poor feeding, or a bulging fontanel.
A characteristic rash is a key feature, often beginning as petechiae on the skin, mucous membranes, or conjunctivae, and progressing to purpura and ecchymoses. In severe cases, the rash may coalesce and become necrotic, leading to purpura fulminans. Rapid deterioration may follow, with hypotension, shock, metabolic acidosis, acute respiratory distress syndrome, and disseminated intravascular coagulation. Meningitis may or may not be present. A particularly severe complication is Waterhouse–Friderichsen syndrome, marked by bilateral adrenal hemorrhage, vasomotor collapse, and acute renal failure due to prolonged hypotension.
Chronic meningococcemia is uncommon and presents as a more indolent illness over weeks to months. Patients are often well appearing but experience recurrent fevers, chills, arthralgias, migratory polyarthritis, intermittent painful rashes on the extremities, and sometimes splenomegaly. Meningococcal meningitis presents with headache, fever, neck stiffness, altered mental status, lethargy, or obtundation. Septic arthritis may occur during active bacteremia and typically involves multiple joints with severe pain, swelling, effusion, and restricted movement. Less common manifestations include conjunctivitis, sinusitis, pneumonia, urethritis, salpingitis, prostatitis, myocarditis, and pericarditis.
Diagnosis is primarily clinical and should be suspected in any patient with fever, rash, and rapid clinical deterioration. Importantly, diagnostic evaluation must never delay resuscitation or antibiotic administration. Gram stain and cultures may be obtained from blood, cerebrospinal fluid, joint aspirates, sputum, urine, or scrapings of petechial or papular lesions, which may reveal intracellular or extracellular gram-negative diplococci. Laboratory findings may include leukocytosis early in disease, followed by leukopenia in severe cases, thrombocytopenia in association with purpura or DIC, metabolic acidosis, renal dysfunction, and abnormal coagulation parameters. Polymerase chain reaction testing is particularly useful when antibiotics have already been administered.
Management requires immediate stabilization with strict attention to airway, breathing, and circulation. Droplet precautions should be instituted, and public health authorities notified. Aggressive fluid resuscitation is essential for hypotension, with vasopressors such as dopamine, norepinephrine, or epinephrine if shock persists. Early endotracheal intubation is indicated for severe hypoxia, acidosis, or altered mental status. Empiric intravenous antibiotics must be started promptly, typically with a third-generation cephalosporin, and later tailored once the diagnosis is confirmed. Penicillin remains an option for proven susceptible infections, while chloramphenicol may be used in penicillin-allergic patients.
Supportive care includes management of metabolic acidosis, monitoring of urine output, treatment of DIC with blood products as indicated, and consideration of corticosteroids in select cases, particularly with adrenal involvement. Surgical intervention, including debridement or amputation, may be required for necrotic tissue in severe disease.
All patients with meningococcemia require hospital admission, with intensive care indicated for those with sepsis or shock. Close contacts must receive prompt postexposure prophylaxis, ideally within 24 hours, using agents such as rifampin, ciprofloxacin, or ceftriaxone. Vaccination is recommended for specific high-risk groups and as part of routine adolescent immunization programs.
Key clinical pearls include maintaining a high index of suspicion, notifying public health authorities immediately, and never delaying antibiotic therapy for diagnostic testing. Rapid progression, early shock, and rash should always prompt consideration of meningococcemia, as early treatment is critical to survival.
Meningococcemia is a serious bacterial illness caused by Neisseria meningitidis. It can present in several clinical forms, ranging from mild, self-limited disease to rapidly fatal overwhelming sepsis. Other manifestations include meningococcal meningitis, chronic or occult meningococcemia, septic arthritis, and less commonly localized infections. Transmission occurs through close contact with an infected person or an asymptomatic carrier, with intimate kissing and cigarette smoking recognized as independent risk factors.
The disease is caused by Neisseria meningitidis, a gram-negative diplococcus with multiple serotypes. Although many serotypes exist, most infections are caused by serogroups A, B, C, X, Y, and W135, with serogroup B being the most common in the United States. The organism colonizes the human nasopharynx, the only natural reservoir, and may invade the bloodstream after penetrating nasopharyngeal epithelial cells. Circulating bacteria are normally cleared by the spleen, but meningococci produce a potent endotoxin, lipooligosaccharide, which plays a central role in vascular injury, skin manifestations, adrenal hemorrhage, and circulatory collapse. Carrier rates increase with age, reaching up to 30–40% in young adults, while young children have lower immunity and higher infection risk. Disease incidence peaks in fall and spring and is higher in crowded living conditions such as military barracks and dormitories.
Clinical presentation varies widely. Mild meningococcemia is the most common form and is often preceded by an upper respiratory infection. Patients develop fever, chills, myalgias, arthralgias, and malaise, and the illness may resolve spontaneously over several days. However, this form can progress to meningitis or overwhelming sepsis. Overwhelming meningococcal sepsis occurs in approximately 10% of cases and carries a high mortality rate, with most deaths occurring within the first 48 hours. The onset is abrupt, and early symptoms may appear deceptively mild, including low-grade tachycardia, tachypnea, hypotension, fever, vomiting, headache, rash, and muscle tenderness. Infants may present with lethargy, poor feeding, or a bulging fontanel.
A characteristic rash is a key feature, often beginning as petechiae on the skin, mucous membranes, or conjunctivae, and progressing to purpura and ecchymoses. In severe cases, the rash may coalesce and become necrotic, leading to purpura fulminans. Rapid deterioration may follow, with hypotension, shock, metabolic acidosis, acute respiratory distress syndrome, and disseminated intravascular coagulation. Meningitis may or may not be present. A particularly severe complication is Waterhouse–Friderichsen syndrome, marked by bilateral adrenal hemorrhage, vasomotor collapse, and acute renal failure due to prolonged hypotension.
Chronic meningococcemia is uncommon and presents as a more indolent illness over weeks to months. Patients are often well appearing but experience recurrent fevers, chills, arthralgias, migratory polyarthritis, intermittent painful rashes on the extremities, and sometimes splenomegaly. Meningococcal meningitis presents with headache, fever, neck stiffness, altered mental status, lethargy, or obtundation. Septic arthritis may occur during active bacteremia and typically involves multiple joints with severe pain, swelling, effusion, and restricted movement. Less common manifestations include conjunctivitis, sinusitis, pneumonia, urethritis, salpingitis, prostatitis, myocarditis, and pericarditis.
Diagnosis is primarily clinical and should be suspected in any patient with fever, rash, and rapid clinical deterioration. Importantly, diagnostic evaluation must never delay resuscitation or antibiotic administration. Gram stain and cultures may be obtained from blood, cerebrospinal fluid, joint aspirates, sputum, urine, or scrapings of petechial or papular lesions, which may reveal intracellular or extracellular gram-negative diplococci. Laboratory findings may include leukocytosis early in disease, followed by leukopenia in severe cases, thrombocytopenia in association with purpura or DIC, metabolic acidosis, renal dysfunction, and abnormal coagulation parameters. Polymerase chain reaction testing is particularly useful when antibiotics have already been administered.
Management requires immediate stabilization with strict attention to airway, breathing, and circulation. Droplet precautions should be instituted, and public health authorities notified. Aggressive fluid resuscitation is essential for hypotension, with vasopressors such as dopamine, norepinephrine, or epinephrine if shock persists. Early endotracheal intubation is indicated for severe hypoxia, acidosis, or altered mental status. Empiric intravenous antibiotics must be started promptly, typically with a third-generation cephalosporin, and later tailored once the diagnosis is confirmed. Penicillin remains an option for proven susceptible infections, while chloramphenicol may be used in penicillin-allergic patients.
Supportive care includes management of metabolic acidosis, monitoring of urine output, treatment of DIC with blood products as indicated, and consideration of corticosteroids in select cases, particularly with adrenal involvement. Surgical intervention, including debridement or amputation, may be required for necrotic tissue in severe disease.
All patients with meningococcemia require hospital admission, with intensive care indicated for those with sepsis or shock. Close contacts must receive prompt postexposure prophylaxis, ideally within 24 hours, using agents such as rifampin, ciprofloxacin, or ceftriaxone. Vaccination is recommended for specific high-risk groups and as part of routine adolescent immunization programs.
Key clinical pearls include maintaining a high index of suspicion, notifying public health authorities immediately, and never delaying antibiotic therapy for diagnostic testing. Rapid progression, early shock, and rash should always prompt consideration of meningococcemia, as early treatment is critical to survival.
- Published on
KembaraXtra – Medicine – Ménière Disease
Ménière disease is a chronic disorder of the inner ear characterized by recurrent, spontaneous episodes of vertigo accompanied by sensorineural hearing loss, tinnitus, and a sensation of aural fullness. The condition most commonly affects one ear, although bilateral involvement may occur in up to 40% of patients. The estimated incidence is approximately 15 per 100,000 people in the United States, with a slight female predominance. Although Ménière disease can occur at any age, it most frequently presents between 40 and 60 years of age. While benign and nonfatal, it can lead to significant morbidity due to the unpredictability and severity of symptoms.
The etiology of Ménière disease is idiopathic, with endolymphatic hydrops considered the primary underlying mechanism. This condition results from impaired drainage of endolymph from the endolymphatic sac and duct, leading to increased pressure within the endolymphatic system. Elevated pressure may cause rupture of the membrane separating potassium-rich endolymph from potassium-poor perilymph, resulting in abnormal stimulation and transient dysfunction of vestibular and cochlear nerve receptors. Additional proposed contributors include structural abnormalities of the endolymphatic system, autoimmune processes, genetic predisposition, remote viral injury, and ischemia of the inner ear. It is important to distinguish Ménière disease from secondary Ménière syndrome caused by conditions such as thyroid disease, syphilis, autoimmune inner ear disease, or medication effects.
Diagnosis is based primarily on clinical features supported by neurotologic evaluation. Definitive diagnosis requires histopathologic confirmation and therefore can only be made postmortem, though modern MRI techniques may provide supportive evidence. Diagnostic criteria include at least two spontaneous episodes of vertigo lasting 20 minutes or longer, at least one documented episode of sensorineural hearing loss on audiometric testing, and the presence of tinnitus or aural fullness in the affected ear. Based on the completeness of findings, cases are categorized as definite, probable, or possible Ménière disease.
Patients typically present with the classic tetrad of vertigo, hearing loss, tinnitus, and aural fullness. Vertigo attacks last from minutes to hours and are frequently associated with nausea and vomiting. Hearing loss is sensorineural, fluctuating, and progressive, often initially affecting low frequencies before potentially involving all frequencies over time. Tinnitus is commonly low-pitched and described as roaring, while aural fullness is perceived as pressure or congestion in the affected ear. Attacks usually reach peak intensity rapidly and resolve gradually, leaving patients fatigued and unsteady for hours to days. Some individuals may be asymptomatic between episodes, while others experience persistent imbalance. Sudden drop attacks without loss of consciousness may also occur.
Physical examination findings vary depending on whether the patient is evaluated during or between attacks. During acute episodes, patients may appear pale, diaphoretic, and distressed. Horizontal nystagmus and impaired hearing are commonly observed. Tuning fork testing often reveals lateralization away from the affected ear on Weber testing, with preserved air conduction on Rinne testing. Romberg testing may demonstrate postural instability, particularly with eyes closed. A thorough neurologic and otologic examination is essential to exclude central nervous system pathology or alternative peripheral ear disorders.
The essential evaluation includes a detailed history and complete neurologic examination. Neuroimaging is warranted when central causes of vertigo are suspected or when focal neurologic deficits are present, particularly in patients with new unilateral hearing loss. Audiometric testing is critical for documenting sensorineural hearing loss, and additional vestibular studies such as caloric testing, electronystagmography, or electrocochleography are typically performed in the outpatient setting. Laboratory investigations are reserved for suspected systemic or secondary causes.
Management in the acute setting focuses on symptom control and exclusion of life-threatening conditions such as stroke. Patients should be protected from falls and maintained in a comfortable position. Intravenous fluids are indicated for dehydration due to vomiting. Benzodiazepines and antiemetics are first-line therapies for acute vertigo and nausea, with antihistamines used as adjuncts. Long-term management aims to reduce the frequency and severity of attacks through dietary sodium restriction, avoidance of triggers such as caffeine and alcohol, diuretics, corticosteroids, and selected transtympanic therapies. Surgical interventions are reserved for patients with severe, refractory disease.
Disposition depends on symptom severity and response to treatment. Admission is indicated for patients with intractable vertigo, persistent vomiting, dehydration, or inability to ambulate safely. Most patients can be discharged once symptoms are controlled, oral intake is tolerated, gait is stable, and neurologic examination is normal. Discharged patients should receive fall precautions and counseling to avoid driving or hazardous activities until symptoms have resolved and sedating medications have been discontinued. Outpatient follow-up with otolaryngology, otology, or neurology is recommended for further evaluation, audiometry, and long-term management.
- Published on
Emergency and Acute Medicine – Meningitis
Basics description
Meningitis is an infection of the central nervous system characterized by inflammation of the leptomeninges and an increased white blood cell count in the cerebrospinal fluid (CSF). It commonly presents with fever, headache, neck stiffness, and altered mental status, although manifestations vary by age and immune status.
Etiology
Meningitis may be bacterial, viral, fungal, or noninfectious in origin. In neonates, common bacterial causes include group B Streptococcus, Escherichia coli, other enteric bacilli, and Listeria monocytogenes. In children and adults, Streptococcus pneumoniae and Neisseria meningitidis predominate, while elderly patients and those with alcoholism are at increased risk for pneumococcal infection, gram-negative bacilli, and Listeria. Neurosurgical patients are more likely to develop infections due to staphylococcal or gram-negative organisms. Immunocompromised patients, including those with AIDS, may develop tuberculosis, fungal, or syphilitic meningitis in addition to typical pathogens. Viral meningitis is common and often less severe, while chemical, drug-induced, or toxin-related meningitis is rare.
Clinical presentation
Typical symptoms include fever, headache, photophobia, and neck stiffness. Kernig and Brudzinski signs may be present but are neither sensitive nor specific. Patients may also develop altered mental status, seizures, focal neurologic deficits, papilledema, or a petechial or purpuric rash suggestive of meningococcal disease. Associated infections such as sinusitis, otitis media, or pneumonia may provide clues to the source.
Infants and young children often present atypically, with fever or hypothermia, lethargy, poor feeding, vomiting, respiratory distress, apnea, cyanosis, hypotonia, or a bulging fontanelle. Classic meningeal signs are frequently absent in children under one year of age. Elderly or immunocompromised patients may present primarily with confusion and fewer classic symptoms.
Essential workup
Management should begin immediately when meningitis is suspected. Blood cultures should be obtained promptly, followed by empiric antimicrobial therapy without delay, especially if the patient is unstable. Lumbar puncture is recommended for all patients with suspected meningitis unless contraindicated. Neuroimaging prior to lumbar puncture is reserved for patients at risk for herniation, including those with immunodeficiency, recent seizures, focal neurologic deficits, altered consciousness, papilledema, a history of central nervous system disease, or age over 60 years.
CSF analysis includes cell count and differential, glucose, protein, Gram stain, and culture, with additional studies added as clinically indicated. Elevated opening pressure may be present. Typical bacterial meningitis is associated with low CSF glucose, elevated protein, and a high white blood cell count with neutrophil predominance, although early disease may show fewer abnormalities.
Diagnostic tests and interpretation
Laboratory evaluation includes blood cultures, complete blood count, electrolytes, renal function tests, coagulation studies, and serum glucose for comparison with CSF glucose. Imaging such as head CT is used selectively to assess for contraindications to lumbar puncture or complications. Chest radiography may identify pneumonia or tuberculosis when suspected. Polymerase chain reaction testing and antigen detection may assist in identifying viral or bacterial pathogens when cultures are nondiagnostic.
Differential diagnosis
Conditions that may mimic meningitis include encephalitis, intracranial abscess, epidural or spinal abscess, febrile seizures, intracranial hemorrhage, stroke, systemic or central nervous system lupus, malignancy, venous sinus thrombosis, trauma, and metabolic or toxic encephalopathies.
Treatment and emergency management
Initial management focuses on airway, breathing, and circulation, seizure control, and isolation when appropriate. Empiric intravenous antibiotics should be administered as soon as possible, ideally after blood cultures but without delaying treatment for imaging or lumbar puncture. Antimicrobial regimens are selected based on patient age, immune status, and risk factors, with coverage for likely organisms. Vancomycin is added when resistant pneumococcal infection is a concern, and ampicillin is included in older adults and immunocompromised patients for Listeria coverage. Acyclovir should be started when herpes simplex encephalitis is suspected.
Adjunctive corticosteroids may reduce neurologic complications in selected patients, particularly those with pneumococcal meningitis, and should be given before or with the first dose of antibiotics when indicated.
Disposition and follow-up
Hospital admission is required for all patients with known or suspected bacterial meningitis, immunocompromised patients, and any toxic-appearing individual. Discharge from the emergency department is reserved for carefully selected patients with confirmed viral meningitis, stable clinical status, reliable follow-up, and clear discharge instructions coordinated with primary care.
Pearls and pitfalls
Meningitis rarely presents as a simple febrile seizure in children. Delayed recognition or treatment can lead to severe neurologic injury or death, making early empiric therapy essential. When clinical suspicion is high, treatment should never be postponed while awaiting diagnostic confirmation.
- Published on
KembaraXtra-Medicine – Marine Envenomation
Marine envenomation refers to poisoning caused by the sting or bite of marine vertebrate or invertebrate species. These injuries occur in a wide variety of aquatic environments and range from mild local reactions to rapidly fatal systemic toxicity. Common causative organisms include sponges, jellyfish, echinoderms, mollusks, fish, and sea snakes, each producing distinct clinical syndromes based on venom type and mechanism of delivery.
The etiology varies by species. Sponges contain sharp spicules coated with irritants that penetrate the skin and cause dermatitis. Jellyfish and other cnidarians possess nematocysts that eject hollow toxin-filled tubules on contact; box jellyfish are particularly dangerous and can cause death within minutes. Starfish and sea urchins deliver venom through rigid or hollow spines, while sea cucumbers secrete holothurin, a toxin capable of causing severe ocular injury. Cone shells inject potent neurotoxic peptides through dart-like teeth that interfere with neuromuscular transmission. Stingrays, the most common cause of marine envenomation, inject venom via serrated tail spines. Scorpion fish, including lionfish and stonefish, possess dorsal spines with neurotoxic venom, and catfish envenomate through dorsal and pectoral spines. Sea snakes inject highly neurotoxic venom through hollow fangs, leading to neuromuscular blockade.
Clinical presentation depends on the organism involved and the severity of envenomation. Sponge exposure typically causes delayed itching, burning, local swelling, and systemic symptoms such as fever, malaise, nausea, and muscle cramps, with possible skin desquamation weeks later. Jellyfish stings cause immediate pain, burning, wheals, and blistering, while severe cases may progress to neurologic deficits, cardiovascular collapse, respiratory failure, gastrointestinal symptoms, or ocular injury. Echinoderm injuries range from localized pain and edema with starfish to intense pain, muscle aches, hypotension, and respiratory distress with multiple sea urchin stings. Sea cucumber exposure often causes mild dermatitis but may result in severe corneal injury and blindness.
Mollusk envenomation, particularly from cone shells, begins with sharp puncture pain and paresthesias that may progress to paralysis, respiratory failure, dysphagia, syncope, or disseminated intravascular coagulation. Stingray injuries present as puncture wounds or lacerations with severe pain, edema, bleeding, and possible tissue necrosis, along with systemic symptoms such as nausea, hypotension, dysrhythmias, seizures, and paralysis. Scorpion fish stings cause intense pain lasting hours and may be accompanied by fever, delirium, seizures, and hypertension. Catfish injuries result in local pain, swelling, bleeding, muscle spasms, and neuropathic symptoms. Sea snake bites are often initially painless but progress within minutes to hours to muscle pain, paralysis, trismus, dysphagia, renal failure, and coma, with high mortality if untreated.
Diagnosis relies primarily on a thorough history and physical examination. Important historical elements include the time and location of exposure, type of water, activity at the time of injury, geographic location, symptom onset, and mental status changes. Physical examination focuses on airway stability, vital signs, neurologic status, cardiopulmonary findings, and careful inspection of wounds for retained foreign bodies, cellulitis, or blistering. Laboratory evaluation may include complete blood count, electrolytes, renal and liver function tests, urinalysis, and arterial blood gases in severe cases. Soft tissue radiographs may be useful to identify retained spines or foreign bodies.
Initial management begins in the prehospital setting with removal from the water, airway and breathing support, hemorrhage control, and avoidance of further venom activation. In the emergency setting, stabilization of airway, breathing, and circulation is the priority, with intravenous access and fluid resuscitation as needed. Clinicians must be prepared to manage anaphylaxis, respiratory failure, and severe pain. General measures include tetanus prophylaxis, antihistamines for pruritus, corticosteroids for severe reactions, narcotic analgesia, and antibiotics for deep, contaminated, or high-risk wounds.
Definitive treatment is species-specific. Spicule injuries from sponges are managed by drying the skin, removing spicules with adhesive tape, and soaking with vinegar or isopropyl alcohol. Jellyfish stings should be rinsed with seawater, treated with vinegar to inactivate nematocysts, and carefully debrided; box jellyfish stings require urgent antivenom. Echinoderm, cone shell, stingray, scorpion fish, and catfish injuries are treated with nonscalding hot water immersion for pain relief and venom inactivation, along with wound exploration and spine removal. Stonefish and sea snake envenomations require specific antivenoms, and sea snake bites necessitate early immobilization, pressure bandaging, and preparation for assisted ventilation.
Patients with systemic toxicity, severe local injury, or need for antivenom require hospital admission. Those without systemic symptoms after adequate observation may be discharged with wound care instructions and follow-up. Key clinical pearls include recognizing that most marine toxins are inactivated by heat or acidic solutions, avoiding fresh water on jellyfish stings, and securing antivenom early when indicated, as supplies are limited and delays can be fatal.
Marine envenomation refers to poisoning caused by the sting or bite of marine vertebrate or invertebrate species. These injuries occur in a wide variety of aquatic environments and range from mild local reactions to rapidly fatal systemic toxicity. Common causative organisms include sponges, jellyfish, echinoderms, mollusks, fish, and sea snakes, each producing distinct clinical syndromes based on venom type and mechanism of delivery.
The etiology varies by species. Sponges contain sharp spicules coated with irritants that penetrate the skin and cause dermatitis. Jellyfish and other cnidarians possess nematocysts that eject hollow toxin-filled tubules on contact; box jellyfish are particularly dangerous and can cause death within minutes. Starfish and sea urchins deliver venom through rigid or hollow spines, while sea cucumbers secrete holothurin, a toxin capable of causing severe ocular injury. Cone shells inject potent neurotoxic peptides through dart-like teeth that interfere with neuromuscular transmission. Stingrays, the most common cause of marine envenomation, inject venom via serrated tail spines. Scorpion fish, including lionfish and stonefish, possess dorsal spines with neurotoxic venom, and catfish envenomate through dorsal and pectoral spines. Sea snakes inject highly neurotoxic venom through hollow fangs, leading to neuromuscular blockade.
Clinical presentation depends on the organism involved and the severity of envenomation. Sponge exposure typically causes delayed itching, burning, local swelling, and systemic symptoms such as fever, malaise, nausea, and muscle cramps, with possible skin desquamation weeks later. Jellyfish stings cause immediate pain, burning, wheals, and blistering, while severe cases may progress to neurologic deficits, cardiovascular collapse, respiratory failure, gastrointestinal symptoms, or ocular injury. Echinoderm injuries range from localized pain and edema with starfish to intense pain, muscle aches, hypotension, and respiratory distress with multiple sea urchin stings. Sea cucumber exposure often causes mild dermatitis but may result in severe corneal injury and blindness.
Mollusk envenomation, particularly from cone shells, begins with sharp puncture pain and paresthesias that may progress to paralysis, respiratory failure, dysphagia, syncope, or disseminated intravascular coagulation. Stingray injuries present as puncture wounds or lacerations with severe pain, edema, bleeding, and possible tissue necrosis, along with systemic symptoms such as nausea, hypotension, dysrhythmias, seizures, and paralysis. Scorpion fish stings cause intense pain lasting hours and may be accompanied by fever, delirium, seizures, and hypertension. Catfish injuries result in local pain, swelling, bleeding, muscle spasms, and neuropathic symptoms. Sea snake bites are often initially painless but progress within minutes to hours to muscle pain, paralysis, trismus, dysphagia, renal failure, and coma, with high mortality if untreated.
Diagnosis relies primarily on a thorough history and physical examination. Important historical elements include the time and location of exposure, type of water, activity at the time of injury, geographic location, symptom onset, and mental status changes. Physical examination focuses on airway stability, vital signs, neurologic status, cardiopulmonary findings, and careful inspection of wounds for retained foreign bodies, cellulitis, or blistering. Laboratory evaluation may include complete blood count, electrolytes, renal and liver function tests, urinalysis, and arterial blood gases in severe cases. Soft tissue radiographs may be useful to identify retained spines or foreign bodies.
Initial management begins in the prehospital setting with removal from the water, airway and breathing support, hemorrhage control, and avoidance of further venom activation. In the emergency setting, stabilization of airway, breathing, and circulation is the priority, with intravenous access and fluid resuscitation as needed. Clinicians must be prepared to manage anaphylaxis, respiratory failure, and severe pain. General measures include tetanus prophylaxis, antihistamines for pruritus, corticosteroids for severe reactions, narcotic analgesia, and antibiotics for deep, contaminated, or high-risk wounds.
Definitive treatment is species-specific. Spicule injuries from sponges are managed by drying the skin, removing spicules with adhesive tape, and soaking with vinegar or isopropyl alcohol. Jellyfish stings should be rinsed with seawater, treated with vinegar to inactivate nematocysts, and carefully debrided; box jellyfish stings require urgent antivenom. Echinoderm, cone shell, stingray, scorpion fish, and catfish injuries are treated with nonscalding hot water immersion for pain relief and venom inactivation, along with wound exploration and spine removal. Stonefish and sea snake envenomations require specific antivenoms, and sea snake bites necessitate early immobilization, pressure bandaging, and preparation for assisted ventilation.
Patients with systemic toxicity, severe local injury, or need for antivenom require hospital admission. Those without systemic symptoms after adequate observation may be discharged with wound care instructions and follow-up. Key clinical pearls include recognizing that most marine toxins are inactivated by heat or acidic solutions, avoiding fresh water on jellyfish stings, and securing antivenom early when indicated, as supplies are limited and delays can be fatal.
- Published on
Emergency and Acute Medicine – Mastitis
Basics description
Mastitis is an infection of the breast characterized by pain, swelling, erythema, and warmth, most commonly occurring in women who are breast-feeding. Systemic symptoms such as malaise and fever are frequent. Incidence may reach up to one-third of lactating women, with onset typically between 2–3 weeks and several months postpartum, most often before the infant is 3 months old. It is uncommon during the first postpartum week and is more frequent in advanced maternal age and patients with diabetes. Potential complications include recurrence, abscess formation, sepsis, necrotizing fasciitis, fistula, scarring, and breast hypoplasia. In rare cases, mastitis can occur in full-term infants younger than 2 months.
Etiology and risk factors
Staphylococcus aureus is the most common causative organism. Less frequent pathogens include coagulase-negative Staphylococcus, Streptococcus species, Escherichia coli, Haemophilus influenzae, and Candida albicans. Predisposing factors include cracked nipples, poor infant latch, local milk stasis, nipple piercing, poor maternal nutrition, prior mastitis, primiparity, tight bras, sore nipples, short infant frenulum, use of manual breast pumps, and maternal yeast infection.
Diagnosis signs and symptoms
Patients typically present with fever and chills, often exceeding 38.3°C, along with generalized malaise and tachycardia. Local findings include unilateral breast pain, induration, erythema, warmth, and swelling, sometimes in a wedge-shaped distribution. Decreased milk outflow and purulent nipple discharge may occur. Axillary lymphadenopathy can be present.
Essential workup and diagnostic testing
Diagnosis is primarily clinical. Careful breast examination is essential to assess for abscess formation, which may be subtle and is often periareolar. Breast milk cultures are generally unnecessary. Ultrasound should be obtained if abscess is suspected, while mammography is not indicated acutely. In neonates, evaluation for abscess and systemic infection is critical, and a sepsis workup may be required if the infant is febrile or ill appearing.
Differential diagnosis
Conditions to consider include breast engorgement, which is typically bilateral and occurs early postpartum with transient low-grade fever, inflammatory breast carcinoma, cysts or tumors, and breast abscess.
Treatment and emergency management
Breast-feeding should be continued whenever possible, as milk drainage is therapeutic and does not harm the infant. If the infant refuses milk from the affected breast, pumping and discarding milk is recommended. Supportive care includes breast massage, warm or cold compresses, hydration, and optimization of breast-feeding technique, often with lactation consultant support. Mild early cases may resolve without antibiotics. When antibiotics are required, oral therapy for 7–14 days is standard, with dicloxacillin or a first-generation cephalosporin as first-line options. Clindamycin, trimethoprim/sulfamethoxazole, or erythromycin may be used in penicillin-allergic patients or when MRSA is suspected, guided by local resistance patterns. Surgical consultation is indicated for suspected abscess.
Disposition and follow-up
Most patients can be managed as outpatients, with clinical improvement expected within 48 hours of therapy. Admission is indicated for patients requiring incision and drainage under anesthesia, those who are immunocompromised or septic, patients with diabetes and severe infection, and neonates with mastitis. Follow-up with a primary care physician is recommended, and lactation consultant involvement is often beneficial. Persistent or atypical cases should be evaluated to exclude inflammatory breast carcinoma.
Key points and cautions
Discontinuation of breast-feeding increases milk stasis and the risk of abscess formation. Many cases respond to supportive care alone, and unnecessary cessation of breast-feeding is a common and avoidable complication.
- Published on
Emergency and Acute Medicine – Mastoiditis
Basics description
Mastoiditis is inflammation of the mastoid air cells of the temporal bone, most commonly resulting from direct extension of acute purulent otitis media. The middle ear and mastoid air cells communicate through the aditus to the mastoid antrum. In otitis media, inflammatory obstruction of this channel leads to fluid trapping, creating an environment for infection. Clinical manifestations range from mild inflammation of mastoid air cells to aggressive infection with bone destruction and serious intracranial or extracranial complications.
Acute mastoiditis occurs to some degree in all cases of otitis media, with early signs indistinguishable from acute otitis media. As infection progresses, involvement of the periosteum causes periostitis, which may be associated with a subperiosteal abscess. Further progression leads to acute mastoid ostitis (coalescent mastoiditis), characterized by destruction of mastoid trabeculae and coalescence of air cells, sometimes with mastoid empyema or a draining fistula. Untreated disease may result in severe head and neck or intracranial complications.
Masked mastoiditis refers to persistent mastoid infection after partial treatment of otitis media, which may later progress to acute or coalescent mastoiditis. Chronic mastoiditis is defined as infection lasting longer than 3 months. Mastoiditis may also complicate systemic conditions such as leukemia, infectious mononucleosis, sarcoma of the temporal bone, HIV, or Kawasaki disease. Although less common in the antibiotic era, it remains more frequent in infants and young children.
Etiology
Pathogens are similar to those causing otitis media but differ in prevalence. Common organisms in acute mastoiditis include Streptococcus pneumoniae, group A streptococcus, Staphylococcus aureus, and Haemophilus influenzae. Chronic mastoiditis more often involves gram-negative enteric organisms such as Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, and Bacteroides species. Less common causes include Mycobacterium tuberculosis and Aspergillus species in immunocompromised patients. In children, S. pneumoniae remains the most frequent pathogen.
Diagnosis signs and symptoms
Patients commonly present with ear pain, otorrhea, fever, headache, and hearing loss of varying severity. Children may show irritability and a history of recurrent otitis media. Physical examination typically reveals postauricular tenderness, edema, and erythema; lateral and inferior displacement of the auricle; loss of the postauricular crease; swelling of the posterior and superior ear canal wall; and tympanic membrane abnormalities consistent with severe otitis media, including bulging or purulent drainage.
Essential workup and diagnostic testing
Mastoiditis is primarily a clinical diagnosis. Laboratory studies may show leukocytosis. Cultures of otorrhea or surgical drainage are important because of pathogen diversity, and blood cultures should be obtained in toxic-appearing patients. Imaging supports diagnosis and evaluates complications: plain mastoid radiographs may show haziness or opacification but have low sensitivity. CT of the temporal bone is more useful, especially for detecting abscesses, trabecular destruction, and complications. MRI is reserved for suspected intracranial involvement not clarified by CT. Lumbar puncture is indicated if meningitis is suspected. In children, judicious use of CT is recommended to minimize radiation exposure when clinical diagnosis is clear.
Differential diagnosis
Otitis media, cellulitis, otitis externa, scalp infection with posterior auricular lymphadenitis, rubella, trauma to the pinna or postauricular area, and meningitis.
Treatment and emergency management
Initial management follows standard ABCs, with IV fluids for hypotension or dehydration. Prompt initiation of IV antibiotics is essential. Given the increasing role of S. aureus, empiric regimens should include antistaphylococcal coverage until culture results are available, with consideration of antipseudomonal coverage in chronic disease. Otolaryngology consultation is mandatory. Surgical drainage is the definitive therapy for acute or coalescent mastoiditis and is emergent in toxic patients. Procedures may include myringotomy with tympanostomy tube placement or mastoidectomy with drainage, required in approximately half of cases. Analgesia with NSAIDs or opioids should be provided.
Disposition and follow-up
All patients with suspected acute or coalescent mastoiditis require admission. Discharge is not appropriate in these cases. Otolaryngology follow-up is essential, and audiography should be performed after resolution to assess for hearing loss.
Complications
Potential complications include Bezold abscess, petrositis, calvarial osteomyelitis, subperiosteal abscess, subdural empyema, and dural venous sinus thrombosis.
Key points and pitfalls
Maintain a high index of suspicion in patients with persistent or inadequately treated otitis media. Failure to recognize meningitis or intracranial extension is a major pitfall. Definitive management requires timely surgical drainage in addition to antibiotics.
